TheraVet SA Logo

TheraVet SA

Veterinary biotech firm developing treatments for osteoarticular diseases in pets.

ALVET | BR

Overview

Corporate Details

ISIN(s):
BE0974387194
LEI:
984500804EBR3F1EFF71
Country:
Belgium
Address:
Avenue Jean Mermoz 32, 6041 Charleroi

Description

TheraVet SA is a veterinary biotechnology company specializing in the development and commercialization of treatments for osteoarticular diseases in companion animals. The company focuses on creating a portfolio of pharmaceutical products and solutions designed to manage bone and joint conditions, such as osteoarthritis. Its primary objective is to provide innovative therapeutic options to improve the mobility and quality of life for pets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-07 19:57
Informations privilégiées / Autres communiqués
French 197.8 KB
2025-03-07 19:57
Informations privilégiées / Autres communiqués
French 197.8 KB
2025-03-07 00:00
20250307CA _EGEIRO CP eng.pdf
English 183.2 KB
2025-03-07 00:00
20250307 CA_EGEIRO CP.pdf
French 187.0 KB
2025-01-27 00:00
CP 20250127 EURONEXT qualification apport actif H4 acquisition inversée.pdf
French 644.6 KB
2025-01-27 00:00
CP 20250127 EURONEXT qualification apport actif H4 acquisition inversée.pdf
French 644.6 KB
2024-12-12 18:00
Informations privilégiées / Autres communiqués
French 193.7 KB
2024-12-12 00:00
CP_EGEIRO-121224_notification_de_transparence_ARTICLE 14.pdf
French 193.7 KB
2024-12-05 18:00
Informations privilégiées / Autres communiqués
French 182.9 KB
2024-11-18 18:00
Inside Information / Other news releases
English 191.3 KB
2024-11-18 18:00
Informations privilégiées / Autres communiqués
French 165.7 KB
2024-11-18 00:00
EGEIRO-181124_CP démission EB.pdf
French 165.7 KB
2024-10-29 07:30
Inside Information / Other news releases
English 257.0 KB
2024-10-29 07:30
Informations privilégiées / Autres communiqués
French 287.8 KB
2024-10-28 07:30
CP_TheraVet_AG_FR.pdf
French 268.3 KB

Automate Your Workflow. Get a real-time feed of all TheraVet SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TheraVet SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TheraVet SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-11-21 Bastianelli Enrico Board Other 200,000 380,000.00 EUR

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.